Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.4370
-0.0227 (-4.94%)
At close: Jul 17, 2026, 4:00 PM EDT
0.4470
+0.0100 (2.29%)
After-hours: Jul 17, 2026, 4:01 PM EDT
SNTI Market Cap
SNTI has a market cap or net worth of $13.47 million as of July 17, 2026. Its market cap has decreased by -73.77% in one year.
Market Cap
13.47M
Enterprise Value
24.33M
1-Year Change
-73.77%
Ranking
Category
Stock Price
$0.44
ChartMarket Cap Chart
Since May 26, 2021, SNTI's market cap has decreased from $256.04M to $13.47M, a decrease of -94.74%. That is a compound annual growth rate of -43.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 18.17M | -33.56% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 15.52M |
| Vyome Holdings | 15.37M |
| Pasithea Therapeutics | 15.28M |
| Moolec Science | 14.56M |
| Tempest Therapeutics | 14.45M |
| Citius Pharmaceuticals | 14.01M |
| Lexaria Bioscience | 13.87M |
| GT Biopharma | 13.83M |